The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.92

Today's change-0.05 -1.68%
Updated May 3 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.92

Today's change-0.05 -1.68%
Updated May 3 4:00 PM -4GMT. Delayed by at least 15 minutes.

Applied DNA Sciences Inc down (U.S.)$0.05

Applied DNA Sciences Inc closed sharply lower Tuesday, dropping (U.S.)$0.05 or 1.68% to (U.S.)$2.92. Over the last five days, shares have lost 3.63% and are down 9.88% for the last year to date. This security has outperformed the S&P 500 by 17.55% during the last year.

Key company metrics

  • Open(U.S.) $2.96
  • Previous close(U.S.) $2.97
  • High(U.S.) $3.00
  • Low(U.S.) $2.91
  • Bid / Ask(U.S.) $2.90 / (U.S.) $3.63
  • YTD % change-9.88%
  • Volume33,107
  • Average volume (10-day)48,954
  • Average volume (1-month)84,105
  • Average volume (3-month)107,859
  • 52-week range(U.S.) $2.27 to (U.S.) $9.70
  • Beta0.87
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.34
Updated May 3 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX1.14%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1422
Total other revenue--------
Total revenue1422
Gross profit--------
Total cost of revenue--------
Total operating expense4443
Selling / general / administrative4443
Research & development0100
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-30-2-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-30-2-2
Income after tax-30-2-2
Income tax, total--000
Net income-30-2-2
Total adjustments to net income--------
Net income before extra. items-30-2-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-30-2-2
Inc. avail. to common incl. extra. items-30-2-2
Diluted net income-30-2-2
Dilution adjustment--------
Diluted weighted average shares23222117
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.02-0.08-0.11
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.13-0.02-0.08-0.11